Recombinant activated factor VII as a promising adjuvant therapy for postpartum hemorrhage in the practice of obstetric anesthesia: Experience from a university hospital in Taiwan

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 7, 2011, Pages 901-907

  Jan, Jing Yi ^a   Lin, Shin Yu ^a   Lin, Chia Hui ^a   Lee, Chien Nan ^a   Fan, Shou Zen ^a   Han, Yin Yi ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coagulopathy; Hysterectomy; Obstetric anesthesia; Postpartum hemorrhage; Recombinant activated factor VII

Indexed keywords

FRESH FROZEN PLASMA; METHYLERGOMETRINE; OXYTOCIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLEEDING; CHORIOAMNIONITIS; CLINICAL ARTICLE; DISEASE CONTROL; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDICATION; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HYSTERECTOMY; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; OBSTETRIC ANESTHESIA; PLACENTA ACCRETA; POSTOPERATIVE PERIOD; POSTPARTUM HEMORRHAGE; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SINGLE DRUG DOSE; TAIWAN; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; UTERINE ATONY; VAGINAL DELIVERY;

ADULT; ANESTHESIA, OBSTETRICAL; DRUG RESISTANCE; FACTOR VIIA; HEMOSTATICS; HOSPITALS, UNIVERSITY; HUMANS; MALE; OFF-LABEL USE; POSTPARTUM HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TAIWAN; TIME FACTORS; YOUNG ADULT;

EID: 80052784040     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01422.x     Document Type: Article

References (27)

1. Kessler CM. New products for managing inhibitors to coagu-lation factors: A focus on recombinant factor VIIa concentrate. Curr Opin Hematol 2000; 7: 408-413.
2. Hedner U, Erhardtsen E. Potential role for rFVIIa in transfu-sion medicine. Transfusion 2002; 42: 114-124.
3. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999; 354: 1879.
4. Mayer SA, Brun NC, Begtrup K et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-785.
5. Friederich PW, Henny CP, Messelink EJ et al. Effect of recom-binant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial. Lancet 2003; 361: 201-205. (Pubitemid 36126219)
6. Lodge JP, Jonas S, Oussoultzoglou E et al. Recombinant coagulation factor VIIa in major liver resection: A randomized, placebo-controlled, double-blind clinical trial. Anesthesiology 2005; 102: 269-275. (Pubitemid 40189073)
7. Singi SR, Fernandez E, Pandya ST, Badrinath HR. Recombi-nant factor VIIa: Use in fatal post partum hemorrhage -Indian experience case series and review of literature. Indian J Hematol Blood Transfus 2009; 25: 1-5.
8. Moscardo F, Perez F, de la Rubia J et al. Successful treatment of severe intra-abdominal bleeding associated with dissemi-nated intravascular coagulation using recombinant activated factor VII. Br J Hematol 2001; 114: 174-176. (Pubitemid 32702652)
9. Haynes J, Laffan M, Plaat F. Use of recombinant activated factor VII in massive obstetric hemorrhage. Int J Obstet Anesth 2007; 16: 40-49. (Pubitemid 44909444)
10. Alfirevic Z, Elbourne D, Pavord S et al. Use of recombinant activated factor VII in primary postpartum hemorrhage: The Northern European registry 2000-2004. Obstet Gynecol 2007; 110: 1270-1278. (Pubitemid 351326069)
11. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum hemorrhage. Br J Anesth 2005; 94: 592-595. (Pubitemid 40613803)
12. Hossain N, Shamsi T, Haider S et al. Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstet Gynecol Scand 2007; 86: 1200-1206. (Pubitemid 47463714)
13. Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major postpar-tum hemorrhage. Acta Anesthesiol Scand 2007; 51: 929-936. (Pubitemid 47062987)
14. Barillari G, Frigo MG, Casarotto M et al. Use of recombinant activated factor VII in severe post-partum hemorrhage: Data from the Italian Registry: A multicentric observational retro-spective study. Thromb Res 2009; 124: e41.
15. Franchini M, Lippi G, Franchi M. The use of recombinant activated factor VII in obstetric and gynaecological hemor-rhage. BJOG 2007; 114: 8-15. (Pubitemid 44923926)
16. McMorrow RC, Ryan SM, Blunnie WP et al. Use of recombi-nant factor VIIa in massive post-partum hemorrhage. Eur J Anesthesiol 2008; 25: 293-298. (Pubitemid 351365302)
17. Phillips LE, McLintock C, Pollock W et al. Recombinant acti-vated factor VII in obstetric hemorrhage: Experiences from the Australian and New Zealand Hemostasis Registry. Anesth Analg 2009; 109: 1908-1915.
18. Tanchev S, Platikanov V, Karadimov D. Administration of recombinant factor VIIa for the management of massive bleeding due to uterine atonia in the post-placental period. Acta Obstet Gynecol Scand 2005; 84: 402-403. (Pubitemid 40478193)
19. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: A systematic review. Lancet 2006; 367: 1066-1074.
20. Bouwmeester FW, Bolte AC, van Geijn HP. Pharmacological and surgical therapy for primary postpartum hemorrhage. Curr Pharm Des 2005; 11: 759-773. (Pubitemid 40347979)
21. Sobieszczyk SBG. Management recommendations for post-partum hemorrhage. Arch Perinat Med 2004; 10: 4.
22. Combs CA, Murphy EL, Laros RK Jr. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991; 77: 69-76.
23. Combs CA, Murphy EL, Laros RK Jr. Factors associated with hemorrhage in cesarean deliveries. Obstet Gynecol 1991; 77: 77-82.
24. Eddy VA, Morris JA Jr, Cullinane DC Hypothermia, coagul-opathy and acidosis. Surg Clin North Am 2000; 80: 845-854.
25. Martinowitz U, Michaelson M. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: A report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Hemost 2005; 3: 640-648. (Pubitemid 41647873)
26. Welsh A, McLintock C, Gatt S, Somerset D, Popham P, Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric hemorrhage. Aust N Z J Obstet Gynaecol 2008; 48: 12-16. (Pubitemid 351239149)
27. Klitgaard T, Nielsen TG. Overview of the human pharmaco-kinetics of recombinant activated factor VII. Br J Clin Pharmacol 2008; 65: 3-11. (Pubitemid 350265177)